Healthcare providers in the UK are caught between two competing demands: deploying powerful AI systems that improve patient outcomes, and meeting legal obligations to explain clinical decisions transparently when things go wrong. A new analysis published in Cureus reveals that algorithmic opacity in high-risk clinical settings may fundamentally undermine clinicians' ability to satisfy their legal "Duty of Candour," a UK requirement to provide truthful, meaningful explanations to patients following safety incidents.

Why Can't Doctors Explain What Their AI Systems Are Doing?

The problem is straightforward but troubling: many of today's most accurate clinical AI systems, particularly deep neural networks, operate as computational black boxes. Clinicians can see the output (a risk score, a diagnosis suggestion), but they cannot see the internal reasoning that produced it. When a patient is harmed and a clinician is asked "Why did your system classify my condition as low-risk?" the honest answer is often "I don't know, and the vendor won't tell me."

The research team at Cureus illustrates this tension through a clinically realistic scenario: a 58-year-old woman presents to an emergency department with confusion and malaise. An AI triage system trained on historical patient data classifies her as low-risk for sepsis, so she is deprioritized. Hours later, she deteriorates into septic shock. Post-incident investigation reveals the system had heavily weighted heart rate as a sepsis indicator, but the patient was on beta-blockers, which suppress tachycardia. The system never "learned" to recognize confusion as a warning sign. Yet when asked to explain its reasoning, the system cannot, and the software vendor cites proprietary constraints.

This is not merely a technical problem. Under UK law, specifically Regulation 20 of the Health and Social Care Act 2008, healthcare organizations must act with openness and transparency following notifiable patient safety incidents, informing patients about what happened and why. Simultaneously, the General Medical Council (GMC) maintains that clinicians remain personally responsible for decisions made with digital assistance, even when they cannot fully understand the system's logic.

How Does Algorithmic Opacity Differ From Ordinary Clinical Uncertainty?

The research distinguishes between two types of uncertainty clinicians face. Ordinary clinical uncertainty arises from the inherent complexity of medicine itself: a patient's symptoms may be ambiguous, test results may be inconclusive, or disease progression may be unpredictable. This is expected and manageable. Structural opacity, by contrast, is created by system design. It arises when a vendor deliberately withholds model architecture, feature weights, or decision logic to protect intellectual property or competitive advantage.

The ethical problem with structural opacity is that it weakens three critical pillars of clinical accountability: traceability (the ability to trace how a decision was reached), accountability (the ability to assign responsibility), and meaningful explanation (the ability to tell a patient what happened and why). When these pillars crumble, clinicians cannot fulfill their professional and legal obligations, even if they want to.

What Does a Risk-Stratified Approach to AI Interpretability Look Like?

The Cureus analysis argues that interpretability should not be treated as an optional technical feature subordinate to predictive accuracy. Instead, it should be treated as a safety-relevant ethical requirement, with the level of required interpretability scaled to the clinical risk profile of the tool.

Consider the difference between an AI system that flags routine administrative tasks versus one that recommends whether to escalate a critically ill patient to intensive care. The stakes are vastly different. A low-risk administrative tool might tolerate some opacity in exchange for higher accuracy. A high-risk clinical tool, particularly one involved in emergency triage or sepsis detection, should not.

• Emergency Department Triage: AI systems that determine which patients are seen first carry immediate life-or-death consequences and should require high interpretability so clinicians can understand and challenge the system's risk assessments in real time.
• Diagnostic Support: Systems that assist with radiological interpretation or pathology analysis should provide explainable reasoning, particularly when they disagree with human judgment or when the stakes involve treatment decisions.
• Risk Stratification: Predictive models that identify patients at risk for deterioration, sepsis, or adverse outcomes must be interpretable because clinicians need to understand which variables triggered alerts and whether those variables are clinically plausible for the individual patient.

How Can Healthcare Systems Balance Accuracy and Explainability?

A parallel research direction, published in IntechOpen, suggests that hybrid computational approaches may offer a path forward. Rather than choosing between mechanistic interpretability and predictive power, researchers are exploring models that combine biophysical principles with machine learning.

These hybrid approaches integrate electrophysiological data (such as heart rhythms or brain signals), biophysical models (equations that describe how signals propagate through tissue), and AI algorithms trained on large datasets. The result is a system that is both interpretable and accurate. A cardiologist can understand why a model predicts an arrhythmia risk because the prediction is grounded in known biophysical mechanisms, not hidden in a neural network's weights.

"By synthesizing electrophysiology, biophysics, and AI into human-centric computational models, medicine can become more precise, predictive, and personalized. This convergence advances scientific understanding, empowers clinicians, improves patient outcomes, and reshapes the practice of modern medicine and surgery," noted researchers at the Korea Advanced Institute of Science and Technology.

Chitaranjan Mahapatra, Korea Advanced Institute of Science and Technology

The IntechOpen analysis emphasizes that this integration is timely because healthcare systems are increasingly adopting digital technologies, and clinicians demand tools that are not only accurate but also explainable and adaptable to diverse patient populations. Applications already span cardiology (predicting arrhythmias), neurology (monitoring seizures), oncology (simulating tumor growth), and surgery (guiding robotic interventions).

What Are the Practical Implications for Healthcare Organizations?

The Cureus analysis reframes interpretability not as a technical preference but as a context-dependent ethical requirement linked to the normative structure of clinical responsibility. For healthcare organizations deploying AI, this has concrete implications:

• Vendor Accountability: Organizations should demand that AI vendors provide sufficient transparency about model architecture, feature importance, and decision logic, particularly for high-risk applications. Proprietary constraints should not override the clinician's legal obligation to explain decisions to patients.
• Clinical Governance: Before deploying an AI system, healthcare organizations should conduct a risk assessment that maps the clinical risk tier of the tool against its required level of interpretability. High-risk tools should not be deployed if they cannot be meaningfully explained.
• Training and Oversight: Clinicians using AI systems should be trained to understand the system's limitations, to recognize when outputs seem implausible, and to maintain their own clinical judgment as the final arbiter of patient care decisions.

The broader implication is that the "Transparency Paradox" identified in the Cureus paper is not inevitable. As AI systems become more sophisticated, they do not necessarily become less explainable. But achieving both accuracy and interpretability requires deliberate design choices, vendor transparency, and a commitment to human-centric principles that prioritize clinician accountability and patient trust over raw predictive performance.